EPO and chronic kidney disease: Indeed, in several observational studies in patients affected by CKD in conservative treatment, the PTH seemed to be related to the worse management of anemia, through impairment of the erythrocytes’ median of fragility (MOF) and increased EPO resistance [29,30,31], but few studies were conducted in dialysis patients only.